Samir Gharib
2020
In 2020, Samir Gharib earned a total compensation of $793.4K as Chief Financial Officer at SPRUCE BIOSCIENCES.
Compensation breakdown
| Non-Equity Incentive Plan | $113,865 |
|---|---|
| Option Awards | $452,165 |
| Salary | $227,354 |
| Total | $793,384 |
Gharib received $452.2K in option awards, accounting for 57% of the total pay in 2020.
Gharib also received $113.9K in non-equity incentive plan and $227.4K in salary.
Rankings
In 2020, Samir Gharib's compensation ranked 9,534th out of 13,090 executives tracked by ExecPay. In other words, Gharib earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,534 out of 13,090 | 27th |
Division Manufacturing | 4,086 out of 5,624 | 27th |
Major group Chemicals And Allied Products | 1,664 out of 2,257 | 26th |
Industry group Drugs | 1,457 out of 1,957 | 26th |
Industry Pharmaceutical Preparations | 1,073 out of 1,462 | 27th |
Source: SEC filing on April 2, 2021.
Gharib's colleagues
We found three more compensation records of executives who worked with Samir Gharib at SPRUCE BIOSCIENCES in 2020.
News
SPRUCE BIOSCIENCES CEO Javier Szwarcberg's 2023 pay falls 52% to $2.2M
April 5, 2024
SPRUCE BIOSCIENCES CEO Javier Szwarcberg receives $4.5M in 2022
April 5, 2023
SPRUCE BIOSCIENCES CEO Richard King's 2021 pay jumps 107% to $5.1M
April 7, 2022
SPRUCE BIOSCIENCES CEO Richard King's 2020 pay jumps 349% to $2.5M
April 2, 2021